Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Z Orthop Unfall ; 154(3): 287-93, 2016 Jun.
Article in German | MEDLINE | ID: mdl-27351161

ABSTRACT

BACKGROUND: In the past few years, patient-specific instrumentation (PSI) in knee endoprosthetics has been energetically marketed. PSI can enhance the accuracy of the size and alignment of the prosthesis components. It should also be possible to reduce hospital costs and operating time. It remains unclear whether these putative advantages are achieved in medial unicompartmental knee arthroplasty (UKA). PATIENTS/MATERIAL AND METHODS: Data from 22 patients (24 knees) were analysed retrospectively. The focus was on the reliability of preoperative surgical planning - particularly with regards to the level of experience of the five surgeons involved, who were split into two groups depending on their level of experience, as defined by EndoCert®. Another focus was on the evaluation of actual surgical time and cost effectiveness using PSI. RESULTS: In order to achieve an optimal outcome, preoperative surgical planning had to be modified intraoperatively to a great extent. The femoral component had to be adjusted intraoperatively in 41.7 % of all cases, the tibial component in 58.3 % and the polyethylene insert in 87.5 %. Surgeons equipped with less experience had to change preoperative planning more often than the more experienced surgeons. Utilising PSI increased the operating time of both the less experienced and the more experienced surgeons. PSI planning and lack of surgical experience were the main predictors of increased surgical time. Instead of lowering costs, utilizing PSI increased surgical costs by nearly 1300 $ per case. This was due to increased operating time, license fees and extraordinary expenditure for MRI scans. CONCLUSION: The advertised advantages of PSI were not supported by the data analysed. On the contrary, this technology leads to additional costs, greater operating time and insufficient accuracy in preoperative planning. As not a single study has yet demonstrated better outcomes in terms of alignment and/or function with PSI than with standard instrumentation, additional data are required before PSI can be recommended for routine use in medial UKA.


Subject(s)
Arthroplasty, Replacement, Knee/economics , Arthroplasty, Replacement, Knee/instrumentation , Cost-Benefit Analysis/economics , Health Care Costs/statistics & numerical data , Operative Time , Patient-Centered Care/economics , Preoperative Care/economics , Arthroplasty, Replacement, Knee/statistics & numerical data , Cost-Benefit Analysis/statistics & numerical data , Germany/epidemiology , Humans , Middle Aged , Patient-Centered Care/statistics & numerical data , Preoperative Care/statistics & numerical data , Retrospective Studies
2.
Onkologie ; 27(4): 358-62, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15347890

ABSTRACT

BACKGROUND: Clinical outcome of patients with head and neck squamous cell carcinoma (SCCHN) depends on several risk factors like the presence of locoregional lymph node or distant metastases, stage, localisation and histologic differentiation of the tumour. Circulating tumour cells in the bone marrow indicate a poor prognosis for patients with various kinds of malignoma. The present study examines the clinical relevance of occult tumour cells in patients suffering from SCCHN. PATIENTS AND METHODS: Bone marrow aspirates of 176 patients suffering from SCCHN were obtained prior to surgery and stained for the presence of disseminated tumour cells. Antibodies for cytokeratin 19 were used for immunohistochemical detection with APAAP on cytospin slides. Within a clinical follow-up protocol over a period of 60 months, the prognostic relevance of several clinicopathological parameters and occult tumour cells was evaluated. RESULTS: Single CK19-expressing tumour cells could be detected in the bone marrow of 30.7% of the patients. There is a significant correlation between occult tumour cells in the bone marrow and relapse. Uni- and multivariate analysis of all clinical data showed the metastases in the locoregional lymph system and detection of disseminated tumour cells in the bone marrow to be statistically highly significant for clinical prognosis. CONCLUSION: The detection of minimal residual disease underlines the understanding of SCCHN as a systemic disease. Further examination of such cells will lead to a better understanding of the tumour biology, as well as to improvement of diagnostic and therapeutic strategies.


Subject(s)
Bone Marrow/pathology , Carcinoma, Squamous Cell/pathology , Neoplastic Cells, Circulating/pathology , Otorhinolaryngologic Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy, Needle , Follow-Up Studies , Humans , Immunoenzyme Techniques , Keratins/analysis , Lymphatic Metastasis/pathology , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Neoplasm, Residual/pathology , Prognosis , Statistics as Topic
SELECTION OF CITATIONS
SEARCH DETAIL